Clinical & translational oncology

• 

  Año 2017, Vol. 19, Número 6

  • Exosomal microRNAs in liquid biopsies:: future biomarkers for prostate cancer

    Ann Valentino, S. Crispi, C. Rolfo, Patrick Pauwels, Rafael Sirera Pérez, M. Giallombardo, Carlos Camps Herrero, P. Reclusa

    • Resumen

    págs. 651-657

    

  • Treating patients with ALK-rearranged non-small-cell lung cancer:: mechanisms of resistance and strategies to overcome it

    M. Drizou, N. Syrigos, E. Kotteas

    • Resumen

    págs. 658-666

    

  • Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain

    Manuel Hidalgo Medina, Alberto Carmona Bayonas, R. Álvarez Gallego, Javier Gallego Plazas, Berta Laquente Sáez, T. Macarulla, Andrés Jesús Muñoz Martín, Mercedes Salgado Fernández, Ruth Vera García, J. Adeva, Carmen Guillén Ponce, Javier Blázquez Sánchez, Sara Arévalo Lobera, Agnès Calsina-Berna, I. Ales Díaz

    • Resumen

    págs. 667-681

    

  • Peculiarities of the obese patient with cancer: a national consensus statement by the Spanish Society for the Study of Obesity and the Spanish Society of Medical Oncology

    Pedro Pérez Segura, Alberto Goday Arno, José Manuel García Almeida, J.E. Palacio Abizanda, Lidia Vázquez Tuñas, Susana Monereo Megías, Ramón de las Peñas Bataller, Purificación Martínez de Icaya Ortiz de Urbina, Cristina Grávalos Castro, Albert Lecube Torelló, Ana Blasco Cordellat, Isidoro C. Barneto

    • Resumen

    págs. 682-694

    

  • miR-26a-5p suppresses tumor metastasis by regulating EMT and is associated with prognosis in HCC

    L. Chang, K. Li, T. Guo

    • Resumen

    págs. 695-703

    

  • Role of axillary ultrasound, magnetic resonance imaging, and ultrasound-guided fine-needle aspiration biopsy in the preoperative triage of breast cancer patients

    Israel Barco Nebreda, Marc García Font, Antonio García Fernández, Manuel Fraile, S. González, L. Canales, Josep Maria Laín Llach, C. González, M. C. Vidal, E. Vallejo, J. Deu, A. Pessarrodona, Nuria Giménez Gómez, Carolina Chabrera Sanz

    • Resumen

    págs. 704-710

    

  • Neutrophil to lymphocyte ratio associated with prognosis of lung cancer

    V. Bar Ad, C. Wang, J. Palmer, L. Li, Y. Lai, B. Lu, R.E. Myers, Z. Ye, R. Axelrod, J.M Johnson, M. Werner Wasik, S.W Cowan, N.R Evans, B.T Hehn, C.C Solomides

    • Resumen

    págs. 711-717

    

  • High early growth response 1 (EGR1) expression correlates with resistance to anti-EGFR treatment in vitro and with poorer outcome in metastatic colorectal cancer patients treated with cetuximab

    S. Kumar, J.E Hardingham, T.J. Price, M. Bruhn, Y. Tomita, J. Wrin, A. Swalling, M. Mohammed

    • Resumen

    págs. 718-726

    

  • Results of a multicenter survey showing interindividual variability among neurosurgeons when deciding on the radicality of surgical resection in glioblastoma highlight the need for more objective guidelines

    J. Capellades Font, Carmen Balaña Quintero, P. Teixidor, Gloria Villalba Martínez, C. Hostalot, G. Plans, R. Armengol, S. Medrano, Anna Estival González, R. Luque, S. Gonzalez, M. Gil Gil, Salvador Villà Freixa, Juan Manuel Sepúlveda Sánchez, J.J. García Mosquera

    • Resumen

    págs. 727-734

    

  • A long noncoding RNA UCA1 promotes proliferation and predicts poor prognosis in glioma

    H.-Y. Zhao, Z. Cui, C. Sun

    • Resumen

    págs. 735-741

    

  • The outcomes of radiotherapy and factors that predict overall survival in elderly patients with esophageal squamous cell carcinoma

    H. Yin, C. Wang, H. Zhang

    • Resumen

    págs. 742-749

    

  • Impact of clinicopathological parameters on survival after multiorgan resection among patients with T4 gastric carcinoma:: a systematic review and meta-analysis

    G. Zu, X. Zhang, T. Zhang, Y. Sun, W. Li

    • Resumen

    págs. 750-760

    

  • Pembrolizumab for advanced melanoma:: experience from the Spanish Expanded Access Program

    María González Cao, Lorenzo Alonso Carrión, Ana Arance Fernández, Josep María Piulats Xanco, Iván Márquez Rodas, José Luis Manzano Mozo, Alfonso Berrocal Jaime, G. Crespo, Delvys Rodríguez Abreu, Elisabeth Pérez Ruiz, Miguel Ángel Berciano Guerrero, Ainara Soria, A.G. Castano, E. Espinosa Arranz, Clara Montagut

    • Resumen

    págs. 761-768

    

  • Activity of weekly paclitaxel−cetuximab chemotherapy in unselected patients with recurrent/metastatic head and neck squamous cell carcinoma:: prognostic factors

    I. Pajares Berna, A. Antón Torres, Javier Martínez Trufero, L. Calera Urquizu, Roberto Pazo Cid, Ana Cebollero de Miguel, Mª J. Agustín, M. Lanzuela

    • Resumen

    págs. 769-776

    

  • Nasopharyngeal carcinoma: 30-year experience of a single institution in a non-endemic area

    J. García Lorenzo, M. De Vega, Núria Farré Bernadó, Alberto Codina, O. Gallego Rubio, Xavier León Vintró

    • Resumen

    págs. 777-783